Top
Topic: Preclinical models for evaluating drug sensitivity and resistance

A special issue of Cancer Drug Resistance.

ISSN 2578-532X (Online)

Submission deadline: 31 Jul 2019

Guest Editor(s)

  • Prof. Robert Jacques
    University of Rochester Medical Center, Rochester, United States

    Website | E-mail

Special Issue Introduction

Apparently, there is a disconnect between the knowledge gained from drug resistant cell lines studied in the test tube and the application of this knowledge to tumors in patients. The study of drug resistance in preclinical models that mimic human cancer could bridge this gap. In mouse models various tools to detect ABC transporters in drug resistant tumors can be tested and optimized. Moreover, treatment schedules and the efficacy of inhibitors are more easily investigated in animals than in humans. The special issue on “Preclinical models for evaluating drug sensitivity and resistance” will include Original Articles, Reviews updating the preclinical models in this field. All submissions will undergo rigorous peer revision and will be published free of charge upon acceptance.

Keywords

cells grown, fresh cells, organoids,growth inhibition, cell death, adhesion and invasion, human tumor colony assays, cell lines collections, mice models, PDX, tumor growth, animal models, dog spontaneous tumors

Submission Deadline

31 Jul 2019

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to http://cdrjournal.com/pages/view/author_instructions
For Online Submission, please login at https://www.oaemesas.com/cdr
Submission Deadline: 31 Jul 2019
Contacts: Elaine Gao, Managing Editor, editorial@cdrjournal.com
                 

Published Articles

This special issue is now open for submission.